Clinical Trials Logo

Prematurity clinical trials

View clinical trials related to Prematurity.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 2

NCT ID: NCT01860573 Active, not recruiting - Prematurity Clinical Trials

Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants

Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether providing increased protein to premature infants in the first week of life allows for better growth during the hospital stay and improved developmental outcomes by age 2.

NCT ID: NCT01498133 Active, not recruiting - PREMATURITY Clinical Trials

Skin-to-skin Contact to Promote Bacterial Decolonization in Preterm Infants

Start date: May 2008
Phase: Phase 2
Study type: Interventional

BACKGROUND Decolonization with topical antibiotics is necessary to prevent and / or control outbreaks of multidrug-resistant bacterial infection in the NICU (Neonatal Intensive Care Unit), but can trigger bacterial resistance. The objective of this study was to determine whether skin-to-skin contact of newborns colonized with MRSA (Methicillin-Oxacillin Resistant Staphylococcus Aureus) with their mothers could be an effective alternative for biological control of bacterial colonization. METHODS: The investigators studied 102 newborns admitted to NICU in three public hospitals in São Luís, Brazil. Inclusion criteria were birth weight from 1300 to 1800g, length of stay >4 days, newborns colonized by Staphylococcus aureus and/or Staphylococcus coagulase-negative methicillin-oxacillin resistant and mothers not colonized by these bacteria. Randomization was performed using a computer generated random numbers algorithm. Allocation to intervention and control groups was performed for each eligible newborn using a sealed opaque envelope. In the intervention group (n = 53) mother-infant skin-to-skin contact was held twice a day. The control group (n = 49) received routine care without skin-to-skin contact. There was no masking of newborn's mothers or researchers, but the individuals who carried out bacterial cultures and assessed results were kept blind to group allocation. The primary outcome was decolonization of newborns' nostrils after 7 days of intervention. Safety was assessed by monitoring vital signs of newborns during the intervention. The secondary outcome was emergence of late onset presumed sepsis until the end of hospitalization period or 28 days of life, whatever happened first. FUNDING: CNPq (Brazilian Research Council) and FAPEMA (Maranhão Research Foundation)

NCT ID: NCT01483079 Active, not recruiting - Prematurity Clinical Trials

Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the Neonatal Intensive Care Unit (NICU)

NICU
Start date: December 2011
Phase:
Study type: Observational

Human milk feeding is associated with great benefits to the health and development of infants, especially in premature infants. Some mothers are unable or unwilling to provide breast milk to their infant. The use of donor human milk products for very low birth weight infants as an alternative to cow milk has risen dramatically in the past year. Purpose: To evaluate post-discharge growth and neurodevelopment of infants less than or equal to 1250 grams birth weight receiving an exclusive human milk protein diet.

NCT ID: NCT00515281 Active, not recruiting - Clinical trials for Bronchopulmonary Dysplasia

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

NOVA2
Start date: May 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether inhaled nitric oxide improves the neurological outcome for premature infants.